RUA Life Sciences (GB:RUA) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
RUA Life Sciences reports a robust first-half revenue growth, doubling from last year, driven by increased biomaterials royalties and contract manufacturing revenues. The group’s strategic acquisition of Abiss Group has bolstered its financial standing, with a pre-tax profit of £0.4 million, a significant recovery from a loss last year. The company is also adjusting its accounting year to align better with business planning.
For further insights into GB:RUA stock, check out TipRanks’ Stock Analysis page.